Researchers Call for Better Opioid Detox Support

For the millions of Americans who eventually want to stop taking opioids and the medications used to treat opioid dependence, a new research review delivers a blunt message.

The current approach to opioid detox is falling short, and medical detox needs to be done better. The findings, while based on a UK-led review, speak directly to a problem that is just as real in the United States.

Researchers at Imperial College London reviewed 41 studies, 22 of them from the USA, on people with opioid dependence going through detoxification from substitution therapies such as methadone and buprenorphine.

Their conclusion, published in the journal Addiction, is that addiction services urgently need new strategies to support people who want to live opioid-free.

Why Medical Detox Matters

Opioid withdrawal is intensely uncomfortable and, without support, often pushes people back to use. Globally, about 16 million people have been diagnosed with opioid dependence, and opioids are involved in more than 120,000 overdose deaths a year.

In the United States alone, roughly 4.8 million people had opioid use disorder in 2024, and more than 100,000 drug overdose deaths were recorded that year.

Medication for opioid use disorder, methadone and buprenorphine in particular, keeps many people stable and alive, and for many it is the right long-term treatment. Complete detoxification is not recommended for everyone.

But a substantial number of people do decide they want to come off the medications entirely, and that is where the system struggles. The relapse risk after stopping is real.

US data show that more than half of people return to illicit opioid use after discontinuing buprenorphine, and real-world six-month retention on the medication often sits below 30 to 50 percent.

That gap between wanting to taper and successfully finishing is exactly what the researchers want to close.

What the Researchers Recommend

The review points to several changes that could make medical detox safer and more successful:

• Specialist training for addiction staff on how to manage opioid withdrawal during detox
• Better provision of medications to ease withdrawal symptoms
• Giving patients more control over their own tapering schedule
• Peer support from people who have been through detox themselves
• Psychological support during the process
• More inpatient or residential options for people without a stable home environment

Lead author Amy Bagshaw noted that many people with opioid dependence want to come off opioids and their substitutes at some stage, but few succeed each year.

The review found that fear of withdrawal, low confidence, severe physical symptoms, unstable housing and inadequate professional support all work against people trying to taper.

The Medication Gap

One finding stands out for US readers. The review highlights a shortage of medicines specifically approved to ease opioid withdrawal symptoms, which are often managed with a patchwork of benzodiazepines, antidepressants, antihistamines, and anti-inflammatories.

The one drug licensed to address multiple withdrawal symptoms, lofexidine, is no longer available in the UK.

It remains available in the United States, where clinicians can use it as a non-opioid option to reduce withdrawal symptoms during detox.

Levels of Detox Care Explained

Where detox happens matters as much as how. Under the ASAM framework, medically managed intensive inpatient care suits people at highest medical risk

Medically monitored inpatient detox suits those who need 24-hour nursing, and clinically managed residential settings can support people who are medically stable but lack a safe environment at home.

The review’s call for more inpatient and residential capacity reflects how often an unstable home undermines an otherwise motivated attempt to taper.

Finding Medical Detox

The clearest lesson from this research is that opioid detox works best with medical supervision, the right medication, and ongoing support, not willpower alone.

Never attempt to stop opioids, and never attempt alcohol or benzodiazepine detox, without medical oversight, as unsupervised withdrawal can be dangerous and is a common path back to use and overdose.

If you are considering coming off opioids or opioid maintenance medication, talk with an addiction medicine provider about a supervised taper and the support options around it.

For additional opioid detox support, search detox.com’s list of detox centers to find treatment near you. Call 800-996-6135(Sponsored) to get in contact with a treatment advisor today.